Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Coins2Day.
Page 22 of 100
Newsletters
Nestlé invests another $200 million in Aimmune’s peanut allergy drug
By
Research Team
Health
The Gates Foundation is pledging up to $100 million for the fight against coronavirus
By
Blockchain Reporter
Newsletters
What Andreessen’s ‘Bio Fund III’ means for healthcare
By
Tech Reporter
Newsletters
A vaccine that looked promising for HIV doesn’t work
By
Financial Writer
Health
The first coronavirus drug candidate is set for testing in China
By
Market Analyst
Health
For what ails Super Bowl athletes? Former NFL player talks up a new long-lasting knee treatment
By
Digital Assets Editor
Newsletters
Vertex CEO takes an earnings victory lap right before he exits
By
Digital Assets Editor
Newsletters
Eli Lilly smashed Wall Street projections thanks to its diabetes drugs
By
Investment Desk
Health
How the Wuhan coronavirus spreads and what’s being done about it
By
News Correspondent
Newsletters
Why a drug that costs $2.1 million per dose is on a sales streak
By
Trading Desk
Newsletters
One drug, one patent?
By
Market Analyst
Health
Michael Bloomberg’s radical plan to cut prescription drug costs
By
Blockchain Reporter
Newsletters
Kobe Bryant and the science of grief
By
Blockchain Reporter
Newsletters
The hunt for a coronavirus vaccine begins
By
Market Analyst
Health
Telehealth startup Ro partners with Pfizer to give its ED business a boost
By
Investment Desk